Blood Group Typing Market worth $3.12 Billion | Bio-Rad Laboratories, Inc. (U.S.), Ortho Clinical Diagnostics Major Players in Global Market
The blood group typing market
is projected to reach USD 3.12 Billion by 2021 from USD 1.95 Billion in 2016,
at a CAGR of 9.8%. The increasing demand for blood and blood products, growing
number of road accidents and trauma cases that necessitate blood transfusion,
need for blood grouping during prenatal testing, and increasing usage of blood
group typing in forensic sciences are the major factors...
Blood Group Typing Market | Emerging Economies in Asia Offer Significant Growth Opportunities
The blood group typing market is projected to reach $3.12 billion by 2021 from $1.95 billion in 2016, at a CAGR of 9.8%.
Growth in the blood group typing market is primarily attributed to the increasing demand for blood and blood products, growing number of road accidents and trauma cases that necessitate blood transfusion, need for blood grouping during prenatal testing, and increasing usage of blood...
Key Players in the Blood Group Typing Market Focus on Strategies Such as Product Launches and Acquisitions.
The blood group typing market is consolidated in nature due to the presence of a few large players. The prominent players in the market are Bio-Rad Laboratories, Inc. (U.S.), Grifols, S.A. (Spain), Immucor, Inc. (U.S.), Ortho Clinical Diagnostics, Inc. (U.S.), Quotient, Ltd. (U.S.), Novacyt Group (France), BAG Healthcare GmbH (Germany), Rapid Labs (U.K.), Day medical SA (Switzerland), DIAGAST (France),...
Blood Group Typing Market: What kind of growth is expected in the market?
The blood group typing market is projected to reach USD 3.12 Billion by 2021 from USD 1.95 Billion in 2016, at a CAGR of 9.8%. The increasing demand for blood and blood products, growing number of road accidents and trauma cases that necessitate blood transfusion, need for blood grouping during prenatal testing, and increasing usage of blood group typing in forensic sciences are the major factors fueling...